Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies

Antipsychotic drugs and risk of developing venous thromboembolism and pulmonary embolism: A systematic review and meta-analysis

(2020) Omid Arasteh et al.   Current Vascular Pharmacology

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis

(2019) Maximilian Huhn et al.   LANCET

Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism

(2019) Christine Rarrick et al.   ANNALS OF PHARMACOTHERAPY

Increased risk for venous thromboembolism among patients with concurrent depressive, bipolar, and schizophrenic disorders

(2019) Ching-En Lin et al.   GENERAL HOSPITAL PSYCHIATRY

Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome

(2018) Julio Quezada et al.   CNS DRUGS

Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study

(2018) L.M. Mollard et al.   European Journal of Internal Medicine

Treating depression with adjunctive antipsychotics

(2018) Roger Mulder et al.   BIPOLAR DISORDERS

Predictors of venous thromboembolism recurrence and the bleeding events identified using a Japanese healthcare database

(2017) Mashio Nakamura et al.   Journal of Cardiology

Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies

(2017) Kai-Lin Huang et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pulmonary Embolism and Clozapine Use: A Case Report and Literature Review

(2017) Rakesh K. Gami et al.   PSYCHOSOMATICS

Hemostasis, endothelial stress, inflammation, and the metabolic syndrome

(2017) Gerald Grandl et al.   Seminars in Immunopathology

Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case–control study

(2017) Alenka Premuš Marušič et al.   International Journal of Clinical Pharmacy

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

(2016) Scott M. Stevens et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Bipolar disorder

(2016) Iria Grande et al.   LANCET

Use of antipsychotics and risk of venous thromboembolism in postmenopausal women

(2016) Jun-Ting Liou et al.   THROMBOSIS AND HAEMOSTASIS

Homocysteine-Induced Endothelial Dysfunction

(2015) Wai Keung Christopher Lai et al.   ANNALS OF NUTRITION AND METABOLISM

Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study

(2015) Valentino Conti et al.   BMC Psychiatry

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

(2015) F Salvo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis

(2015) Clive Ballard et al.   Journal of the American Medical Directors Association

Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study

(2015) S. N. Vigod et al.   BMJ-British Medical Journal

Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study

(2015) S. N. Vigod et al.   BMJ-British Medical Journal

Pulmonary thromboembolism due to paliperidone: report of 2 cases

(2014) Melike Ceyhan Balcı Şengül et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

Antipsychotic Drug Exposure and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Corrado Barbui et al.   DRUG SAFETY

Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD

(2014) Chieko Ishiguro et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers

(2013) Lisa Hartling et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Antipsychotic Treatment and the Occurrence of Venous Thromboembolism

(2013) Chi-Shin Wu et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia

(2013) Niklas Schmedt et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Levels of prolactin in relation to coagulation factors and risk of venous thrombosis

(2012) Jan Debeij et al.   THROMBOSIS AND HAEMOSTASIS

Antipsychotic drugs and risk of pulmonary embolism

(2011) Benoit Allenet et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Antipsychotics and Venous Thromboembolism Risk: A Meta-Analysis

(2011) R. Zhang et al.   PHARMACOPSYCHIATRY

Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients

(2010) Stefan Löffler et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients

(2010) Bart C. Kleijer et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation

(2010) Anna Dietrich-Muszalska et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Antipsychotics and risk of venous thromboembolism: A population-based case-control study

(2010) Anna Jönsson   Clinical Epidemiology

Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series

(2009) Anna K. Jönsson et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication

(2009) Krasimira Halacheva et al.   PSYCHIATRY RESEARCH

Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients

(2008) Hong Shen et al.   JOURNAL OF PSYCHIATRIC RESEARCH